RKDA.NASDAQArcadia Biosciences, INC

Form 4: Arcadia Biosciences Director Acquires Stock Options

Sentiment:

SEC Form 4 Filing

📋All filings for Arcadia Biosciences, INC
🔒Login to Follow

Kevin Comcowich, a director at Arcadia Biosciences, acquired stock options for 25,455 shares on August 19, 2024.

Summary

  • On August 19, 2024, Kevin Comcowich, a director of Arcadia Biosciences, acquired stock options for 25,455 shares of common stock at an exercise price of $2.71.
  • The options vest on the earlier of August 19, 2025, or the date of the Issuer's next Annual Meeting of Stockholders, contingent upon continued service.
  • Following the transaction, Comcowich directly owns 31,042 derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

  • The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

DateDescription
08/19/2024Date of the transaction: Kevin Comcowich acquired stock options.
08/19/2024Stock Option (Right to Buy) was acquired.
08/19/2025Earliest vesting date for the stock options.
08/19/2034Expiration date for the stock options.
08/21/2024Date of the signature on the Form 4 filing.

Keywords

stock options, director, RKDA, Arcadia Biosciences, Form 4, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.